%0 Journal Article %T Deactivation of LVAD support for myocardial recovery-surgical perspectives. %A Nickel I %A Potapov E %A Sun B %A Zimpfer D %A Koliopoulou A %A Adachi I %A Anyanwu A %A Falk V %A Atluri P %A Faerber G %A Goldstein D %A Yarboro L %A Slaughter MS %A Milano C %A Tsukashita M %A D'Alessandro D %A Silvestry S %A Kirov H %A Bommareddi S %A Lanmüller P %A Doenst T %A Selzman CH %J J Heart Lung Transplant %V 43 %N 9 %D 2024 Sep 12 %M 38744354 %F 13.569 %R 10.1016/j.healun.2024.05.005 %X Left ventricular assist devices (LVADs) are excellent therapies for advanced heart failure patients either bridged to transplant or for lifetime use. LVADs also allow for reverse remodeling of the failing heart that is often associated with functional improvement. Indeed, growing enthusiasm exists to better understand this population of patients, whereby the LVAD is used as an adjunct to mediate myocardial recovery. When patients achieve benchmarks suggesting that they no longer need LVAD support, questions related to the discontinuation of LVAD therapy become front and center. The purpose of this review is to provide a surgical perspective on the practical and technical issues surrounding LVAD deactivation.